A novel recombinant human anti-PD-1 monoclonal antibody GLS-010 in patients with advanced cancer: Result of a phase Ia clinical trial

被引：0
|
作者：
Shen, L. [1 ]
Gong, J. [1 ]
Xu, Y. [1 ]
Zhang, X. [1 ]
Peng, Z. [1 ]
Qi, C. [1 ]
Li, G. [2 ]
Meng, H. [2 ]
Liu, Z. [2 ]
Wang, H. [2 ]
Chen, C. [3 ]
Li, J. [3 ]
Zheng, Y. [3 ]
Lee, J. [4 ]
Zhang, Y. [4 ]
Zhang, Q. [4 ]
机构：
[1] Peking Univ, Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China
[2] Guangzhou Gloria Biosci Co Ltd, Gloria Biosci, Beijing, Peoples R China
[3] WuXi Biol Shanghai Co Ltd, WuXi Biol, Shanghai, Peoples R China
[4] Wuxi Clin Dev Serv Shanghai Co Ltd, Wuxi Clin, Shanghai, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
65P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma
    Coen, Oliver
    Corrie, Pippa
    Marshall, Helen
    Plummer, Ruth
    Ottensmeier, Christian
    Hook, Jane
    Bell, Sue
    Sagoo, Gurdeep S.
    Meads, David
    Bestall, Janine
    Velikova, Galina
    Gallagher, Ferdia A.
    Smith, Alexandra
    Howard, Helen
    Mason, Ellen
    Katona, Eszter
    Silva, Shobha
    Collinson, Michelle
    Rodwell, Simon
    Danson, Sarah
    BMC CANCER, 2021, 21 (01)
  • [32] A phase Ia/Ib trial of the anti-PD-L1 human monoclonal antibody (mAb), CS1001, in patients (pts) with advanced solid tumors or lymphomas.
    Shen, Lin
    Cao, Junning
    Li, Jin
    Pan, Hongming
    Xu, Nong
    Zhang, Yan
    Wang, Jingru
    Wang, Yin
    Dai, Hangjun
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Preliminary safety, efficacy, and PK/PD characterization from GARNET, a phase I clinical trial of the anti-PD-1 monoclonal antibody, TSR-042, in patients with recurrent or advanced MSI-H endometrial cancer
    Oaknin, A.
    Ellard, S. L.
    Leath, C., III
    Moreno, V.
    Kristeleit, R.
    Guo, W.
    Lu, S.
    Jenkins, D.
    McEachern, K.
    Jen, K. Yu
    Dunlap, S.
    Im, E.
    Gilbert, L.
    ANNALS OF ONCOLOGY, 2018, 29 : 334 - 334
  • [34] Intravenous Delivery of RNA Encoding Anti-PD-1 Human Monoclonal Antibody for Treating Intestinal Cancer
    Wu, Lipei
    Wang, Weiwei
    Tian, Jiale
    Qi, Chunrun
    Cai, Zhengxin
    Yan, Wenhui
    Xuan, Shihai
    Shang, Anquan
    JOURNAL OF CANCER, 2022, 13 (02): : 579 - 588
  • [35] Bgb-A425, an investigational anti-TIM-3 monoclonal antibody, in combination with tislelizumab, an anti-PD-1 monoclonal antibody, in patients with advanced solid tumors: A phase I/II trial in progress.
    Desai, Jayesh
    Meniawy, Tarek
    Beagle, Brandon
    Li, ZheZhen
    Mu, Song
    Wu, John
    Denlinger, Crystal S.
    Messersmith, Wells A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [36] Interim results of a phase 1/2 study of JNJ-63723283, an anti-PD-1 monoclonal antibody, in patients with advanced cancers.
    Calvo, Emiliano
    Moreno, Victor
    Felip, Enriqueta
    Curigliano, Giuseppe
    Morgensztern, Daniel
    Greger, James
    Bae, Kyounghwa
    Mayer, Christina Lourdes
    Marino, Jennifer
    Attiyeh, Edward F.
    Xie, Hong
    Lee, James J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [37] Safety and clinical activity with an anti-PD-1 antibody JS001 in advanced melanoma or urologic cancer patients
    Bixia Tang
    Xieqiao Yan
    Xinan Sheng
    Lu Si
    Chuanliang Cui
    Yan Kong
    Lili Mao
    Bin Lian
    Xue Bai
    Xuan Wang
    Siming Li
    Li Zhou
    Jiayi Yu
    Jie Dai
    Kai Wang
    Jinwei Hu
    Lihou Dong
    Haifeng Song
    Hai Wu
    Hui Feng
    Sheng Yao
    Zhihong Chi
    Jun Guo
    Journal of Hematology & Oncology, 12
  • [38] Open-label, phase I, dose escalation/expansion trial of the anti-SIRPa monoclonal antibody BI 770371 in patients with advanced solid tumours, alone or in combination with the anti-PD-1 monoclonal antibody ezabenlimab
    Gutierrez, M.
    Jamal, R.
    Yamamoto, N.
    Doi, T.
    Elgadi, M.
    Ferrada, J. L.
    Wojciekowski, S. M.
    Patel, M. R.
    ANNALS OF ONCOLOGY, 2023, 34 : S485 - S485
  • [39] Model-based Characterization of the Clinical Pharmacokinetics of Nivolumab, a Fully Human Anti-PD-1 Monoclonal Antibody
    Feng, Yan
    Agrawal, Shruti
    Kollia, Georgia
    Saeger, Sally
    Ullmann, Martin
    Sankar, Vindira
    McDonald, Dan
    Gupta, Ashok
    Masson, Eric
    Roy, Amit
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2013, 40 : S141 - S142
  • [40] Clinical pharmacokinetics (PK) of BMS-936558, a fully human anti-PD-1 monoclonal antibody.
    Agrawal, Shruti
    Feng, Yan
    Kollia, Georgia
    Saeger, Sally
    Ullmann, Martin
    McDonald, Dan
    Gupta, Ashok Kumar
    Roy, Amit
    Masson, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345